Ionis Pharmaceuticals, Inc. Payments of Merger Related Costs, Financing Activities
Ionis Pharmaceuticals, Inc. (IONS) reported Payments of Merger Related Costs, Financing Activities of $0 for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-03.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfMergerRelatedCostsFinancingActivities · last filed 2021-11-03
- 2021-09-30: Payments of Merger Related Costs, Financing Activities 9 month $0.00.
- 2020-09-30: Payments of Merger Related Costs, Financing Activities 9 month $1.07M.
- 2019-09-30: Payments of Merger Related Costs, Financing Activities 9 month $0.00.
| Period end | Payments of Merger Related Costs, Financing Activities 9 month |
|---|---|
| 2021-09-30 | $0.00 10-Q · filed 2021-11-03 |
| 2020-09-30 | $1.07M 10-Q · filed 2021-11-03 |
| 2019-09-30 | $0.00 10-Q · filed 2020-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |